Foresite Capital is a healthcare and life sciences investment firm.
Foresite Capital their funding includes developing generation therapeutics.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 8, 2022
DNAnexus
|
Series H | $200M | Bioinformatics | — |
Jan 6, 2022
Eikon Therapeutics
|
Series B | $518M | Biotechnology | — |
Sep 9, 2021
Mammoth Biosciences
|
Series D | $150M | Biotechnology | — |
Jun 29, 2021
Element Biosciences
|
Series C | $276M | Biotechnology | — |
Jun 28, 2021
HealthVerity
|
Series D | $100M | Health Care | — |